GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LivaNova PLC (NAS:LIVN) » Definitions » Cyclically Adjusted FCF per Share

LivaNova (LivaNova) Cyclically Adjusted FCF per Share : $0.93 (As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is LivaNova Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

LivaNova's adjusted free cash flow per share for the three months ended in Mar. 2024 was $0.066. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.93 for the trailing ten years ended in Mar. 2024.

During the past 12 months, LivaNova's average Cyclically Adjusted FCF Growth Rate was -8.80% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -5.80% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -11.90% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 7.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of LivaNova was 85.50% per year. The lowest was -14.10% per year. And the median was 0.20% per year.

As of today (2024-06-12), LivaNova's current stock price is $52.81. LivaNova's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $0.93. LivaNova's Cyclically Adjusted Price-to-FCF of today is 56.78.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of LivaNova was 167.80. The lowest was 23.45. And the median was 52.14.


LivaNova Cyclically Adjusted FCF per Share Historical Data

The historical data trend for LivaNova's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LivaNova Cyclically Adjusted FCF per Share Chart

LivaNova Annual Data
Trend Apr14 Apr15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.56 1.16 1.20 1.07 0.97

LivaNova Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.02 0.91 0.92 0.97 0.93

Competitive Comparison of LivaNova's Cyclically Adjusted FCF per Share

For the Medical Devices subindustry, LivaNova's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LivaNova's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LivaNova's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where LivaNova's Cyclically Adjusted Price-to-FCF falls into.



LivaNova Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, LivaNova's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.066/131.6000*131.6000
=0.066

Current CPI (Mar. 2024) = 131.6000.

LivaNova Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201404 0.521 99.600 0.688
201407 0.605 99.600 0.799
201410 0.839 100.100 1.103
201501 0.727 99.200 0.964
201504 0.570 99.900 0.751
201507 0.650 100.000 0.855
201510 1.088 100.300 1.428
201603 0.030 100.400 0.039
201606 -0.113 101.000 -0.147
201609 0.499 101.500 0.647
201612 0.640 102.200 0.824
201703 0.532 102.700 0.682
201706 -0.186 103.500 -0.236
201709 0.680 104.300 0.858
201712 0.155 105.000 0.194
201803 0.296 105.100 0.371
201806 0.421 105.900 0.523
201809 0.806 106.600 0.995
201812 0.165 107.100 0.203
201903 -0.078 107.000 -0.096
201906 -0.506 107.900 -0.617
201909 -1.757 108.400 -2.133
201912 -0.038 108.500 -0.046
202003 -2.351 108.600 -2.849
202006 -0.584 108.800 -0.706
202009 -0.038 109.200 -0.046
202012 0.625 109.400 0.752
202103 0.231 109.700 0.277
202106 0.393 111.400 0.464
202109 0.401 112.400 0.469
202112 0.486 114.700 0.558
202203 0.380 116.500 0.429
202206 -0.303 120.500 -0.331
202209 0.553 122.300 0.595
202212 0.179 125.300 0.188
202303 0.243 126.800 0.252
202306 -0.437 129.400 -0.444
202309 0.174 130.100 0.176
202312 0.753 130.500 0.759
202403 0.066 131.600 0.066

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


LivaNova  (NAS:LIVN) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

LivaNova's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=52.81/0.93
=56.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of LivaNova was 167.80. The lowest was 23.45. And the median was 52.14.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


LivaNova Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of LivaNova's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


LivaNova (LivaNova) Business Description

Traded in Other Exchanges
Address
20 Eastbourne Terrace, London, GBR, W2 6LG
U.K.-based LivaNova was born of a combination between Cyberonics in the U.S. and Sorin in Italy. The medical device firm is primarily focused on cardiovascular and cardiopulmonary solutions (with surgical heart valves, heart-lung machines, and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. LivaNova derives roughly half of its revenue from the U.S. market, another 21% from Europe, and the remainder from the rest of the world.
Executives
James Christopher Barry director 7475 LUSK BLVD, SAN DIEGO CA 92121
Damien Mcdonald officer: COO 5 MERCHANT SQUARE, NORTH WHARF ROAD, LONDON X0 W21AY
Michael Damon Hutchinson officer: Chief Legal Officer 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Brooke Story director C/O SIGILON THERAPEUTICS, INC., 100 BINNEY STREET, SUITE 600, CAMBRIDGE MA 02142
Peter M Wilver director
Daniel Jeffrey Moore director 100 CYBERONICS BVLD, HOUSTON TX 77058
Alfred J Novak director 325 NE 6TH ST, BOCA RATON FL 33432
William A Kozy director C/O BECTON DICKERSON & CO, 1 BECTON DR, FRANKLIN LAKES NJ 07417
Marco Dolci officer: SVP Global Operations, R&D VIA BENIGNO CRESPI 17, MILAN L6 20159
Todd C Schermerhorn director C/O C.R BARD INC, 730 CENTRAL AVE, MURRAY HILL NJ 07974
Alex Shvartsburg officer: Interim CFO 20 EASTBOURNE TERRACE, LONDON X0 W26LG
Roy Khoury officer: President, International 5 MERCHANT SQUARE, NORTH WHARF ROAD, LONDON X0 W21AY
Thad Allen Huston officer: Chief Financial Officer 941 BLOOMFIELD ST, HOBOKEN NJ 07030
Seng Stacy Enxing director C/O HILL-ROM HOLDINGS, INC., SUITE 4100 180 NORTH STETSON AVENUE, CHICAGO IL 60601
Trui Hebbelinck officer: Chief Human Resources Officer 20 EASTBOURNE TERRACE, LONDON X0 W2 6LG

LivaNova (LivaNova) Headlines